
NASDAQHealthcareDrug Manufacturers - Specialty & Generic
最新データ
$60.85
−$0.51 · -0.83%
Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkindi Sprinkle for adrenal insufficiency; Khindivi for adrenocortical insufficiency; Galzin for Wilson disease; PKU Golike for phenylketonuria; Carglumic Acid for N-acetylglutamate synthase deficiency; Betaine Anhydrous for homocystinuria; and Nitisinone for tyrosinemia type 1. The company is also developing various product candidates, which are in late-stage development, including ET-600 for diabetes insipidus; Amglidia for neonatal diabetes mellitus; ET-700 for Wilson disease; ET-800 for adrenal insufficiency; and ZENEO hydrocortisone autoinjector for adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.
前日終値
$60.85
−$0.51 · -0.83%
日中の時刻はETです。市場データは遅延する場合があります。
Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkindi Sprinkle for adrenal insufficiency; Khindivi for adrenocortical insufficiency; Galzin for Wilson disease; PKU Golike for phenylketonuria; Carglumic Acid for N-acetylglutamate synthase deficiency; Betaine Anhydrous for homocystinuria; and Nitisinone for tyrosinemia type 1. The company is also developing various product candidates, which are in late-stage development, including ET-600 for diabetes insipidus; Amglidia for neonatal diabetes mellitus; ET-700 for Wilson disease; ET-800 for adrenal insufficiency; and ZENEO hydrocortisone autoinjector for adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.
日中レンジ
現在 $60.85
52週レンジ
現在 $60.85
日中の時刻はETです。市場データは遅延する場合があります。
GoAI スコア
買い
バリュエーション
75
割安
センチメント
68
強気
リスク
34
中程度のリスク
モメンタム
70
上昇基調
GoAIの詳細リサーチ
詳しい根拠、カタリスト、リスクを確認できます。
Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkindi Sprinkle for adrenal insufficiency; Khindivi for adrenocortical insufficiency; Galzin for Wilson disease; PKU Golike for phenylketonuria; Carglumic Acid for N-acetylglutamate synthase deficiency; Betaine Anhydrous for homocystinuria; and Nitisinone for tyrosinemia type 1. The company is also developing various product candidates, which are in late-stage development, including ET-600 for diabetes insipidus; Amglidia for neonatal diabetes mellitus; ET-700 for Wilson disease; ET-800 for adrenal insufficiency; and ZENEO hydrocortisone autoinjector for adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.
日中レンジ
現在 $60.85
52週レンジ
現在 $60.85
利用可能な期間全体で報告されたマージン。
売上高
営業利益
純利益
| 指標(USD) | 2025年度 | 2024年度 | 2023年度 | 2022年度 | 2021年度 |
|---|---|---|---|---|---|
| 売上高 | 7995万 USD | 3901.1万 USD | 3164.2万 USD | 2125.1万 USD | 2183.2万 USD |
| 売上原価 | 3721万 USD | 1560万 USD | 1058.1万 USD | 693.3万 USD | 262.3万 USD |
| 粗利益 | 4274万 USD | 2341.1万 USD | 2106.1万 USD | 1431.8万 USD | 1920.9万 USD |
| 研究開発 | 776.5万 USD | 325.5万 USD | 332.2万 USD | 399.6万 USD | 623.5万 USD |
| 販売・一般管理 | 3581.9万 USD | 2275.3万 USD | 1893.1万 USD | 1858.2万 USD | 1446.9万 USD |
| 営業費用 | 4266.8万 USD | 2600.8万 USD | 2225.3万 USD | 2257.8万 USD | 2070.4万 USD |
| 支払利息 | 478.1万 USD | 200.5万 USD | 106万 USD | 95.5万 USD | 104.2万 USD |
| 減価償却費と償却費 | 404.4万 USD | 114.6万 USD | 90.1万 USD | 177.4万 USD | 46.2万 USD |
| 営業利益 | 7.2万 USD | −259.7万 USD | −119.2万 USD | −826万 USD | −149.5万 USD |
| 純利益 | −460.1万 USD | −382.3万 USD | −93.6万 USD | −902.1万 USD | −195.5万 USD |
会社概要が更新されました 2026年11月22日.
発表済み実績と利用可能なコンセンサス予想。
発表済み実績と利用可能なコンセンサス予想。
この株式へのエクスポージャーを報告している上場投資信託です。
iShares Russell 2000 ETFIWM4369.38万0.06%715.37億 USD0.19%$256.61-2.88%
Vanguard Morningstar Total Stock Market ETFVTI3575.65万0.00%6893億 USD0.03%$340.02-3.52%
Vanguard Extended Market ETFVXF1610.95万0.02%302億 USD0.05%$211.44-3.21%
iShares Russell 2000 Growth ETFIWO1554.22万0.12%127.32億 USD0.24%$320.43-3.57%
State Street SPDR S&P Pharmaceuticals ETFXPH1123.13万2.24%5.01億 USD0.35%$62.15-2.00%
First Trust Small Cap Growth AlphaDEX FundFYC1045.01万0.83%12.57億 USD0.70%$103.45-3.18%
Schwab U.S. Small-Cap ETFSCHA862.72万0.04%204.47億 USD0.03%$30.51-2.83%
Vanguard Russell 2000 ETFVTWO819.16万0.05%168億 USD0.06%$103.76-2.76%
iShares Russell 2000 ETFIWM
Vanguard Morningstar Total Stock Market ETFVTI
Vanguard Extended Market ETFVXF
iShares Russell 2000 Growth ETFIWO
State Street SPDR S&P Pharmaceuticals ETFXPH
First Trust Small Cap Growth AlphaDEX FundFYC
Schwab U.S. Small-Cap ETFSCHA
Vanguard Russell 2000 ETFVTWOAIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。